Objective: Haematological and biochemical measurements are performed routinely before surgery to exclude organ malfunction and blood cell and coagulation abnormalities. We aimed to test routinely obtained laboratory data as factors predicting operative risk. Methods: Between 1996 and 2003, 2198 patients underwent aortic valve replacement (AVR) (908 of them with concomitant CABG) in our institute. The mean age of the study population was 69 AE 11 years (range 13-91, 43% female). Clinical and laboratory parameters based on the consolidated data mart set were evaluated by multiple logistic regression analysis. Results: The overall operative mortality (within 30 days) was 3.8% and the mortality after 3 months was 5.9%. In addition to clinical characteristics, the following laboratory values were identified as independent predictors of 30-day mortality: fasting blood glucose, antithrombine III, partial thromboplastine time and creatinine kinase. As independent predictors of 3-month mortality, the following laboratory values were indentified: fasting blood glucose, serum creatinine, antithrombine III, partial thromboplastine time, lactate dehydrogenase, sodium concentration and serum proteins. The discriminative power of the models increased if laboratory parameters were included in addition to preoperative clinical characteristics (from 0.75 to 0.79 and from 0.75 to 0.78 for 30-day and 3-month mortality, respectively). The discriminative power using the logistic EuroScore was lower (0.71 and 0.7, for 30-day and 3-month mortality, respectively). Conclusions: Laboratory parameters as objective markers for organ function and nutritional status are useful data for the prediction of 30-day and 3-month mortality after aortic valve replacement. Using modern methods of information technology, these valuable data which are stored electronically in most hospitals, can be used efficiently for research and quality control. #
Introduction
The goals of creating predictive models for mortality after cardiac surgery are to identify modifiable risk factors and/or to provide adequate tools for risk-adjusted outcome analysis.
The majority of the models predicting the mortality risk focused on coronary artery bypass grafting (CABG) or on cardiac surgery in general [1] . In risk predicting models for cardiac surgery, patients undergoing aortic valve replacement (AVR) are underrepresented. This may underestimate their risk and hide the real risk factors in these patients.
Recently, more specified studies based on large data sets have identified important risk factors and presented risk models predicting short-term mortality in patients undergoing AVR [2] [3] [4] [5] [6] [7] . However, time-related outcome analysis demonstrated that 30-day mortality is an insufficient endpoint to calculate the risk of AVR, because the surgical procedure has still an impact on mortality beyond 30 days [8] .
The accuracy of predictive models depends beneath the uniformity of the study group and the adequate follow-up on the quality of the underlying data. When predictive models are used as 'common language' by different cardiac surgical units to compare outcome, the subjective definition of variables becomes a major problem. Therefore it is advantageous to replace the subjective assessment of the patient's condition in all risk scores by objective data like laboratory values. We were interested whether routinely obtained laboratory data may improve the prediction of the perioperative risk in patients undergoing AVR.
Materials and methods

Patient population
Between March 1996 and December 2003, 2198 patients underwent AVR either alone or in combination with CABG (41%). This study population included patients receiving mechanical and bioprosthetic valve, but excluded patients with valve repair or multivalve replacement. In 109 of all patients (5%), an aneurysm of the ascending aorta was diagnosed and the ascending aorta was replaced. In Table 1 , the operative and preoperative characteristics of the patient population are shown. The routinely measured data of blood analysis is presented in Table 2 .
Patients were followed either 3 or 6 months after surgery by a mailed questionnaire. Nonresponder or their relatives were contacted by telephone. The follow-up was 100% and 99% complete for 30-day and 3-month mortality, respectively.
Statistical analysis
Statistical analysis was performed using the software package SPSS (SPSS Inc., Chicago, IL, USA).
For each patient included in the present study, 38 preoperative characteristics were used from the consolidated database of our data mart system [9] . The data were based on the anaesthesiological and cardio-surgical quality assurance and the laboratory data of the clinical chemistry. All variables included into the analysis are shown in Tables 1  and 2 . The missing value rate was below 5%. Missing values were completed by the mean for continuous variables and by the most frequent event for categorical variables.
By logistic regression the following categorical outcome variables were analysed: 30-day and 3-month mortality. For variable selection of both multivariate logistic regression models, the Akaike information criterion (AIC = Deviance of the model + 2 Â number of included parameters) was calculated for variables showing a difference for the outcome variable with a p-value smaller or equal to 0.25. The variables were included into multiple regression models in a step wise way. The AIC was calculated each time a variable is included. The final model is reached when no more reduction in AIC is observed.
To verify the linearity assumption of logistic regression model for continuous variables, we divided the range of the continuous independent variable into groups, and for each group we plotted the logit of the outcome variable versus the group midpoint. In the case of a nonlinear increase or decrease of the logit, the continuous variable was transformed (e.g. into dichotomous) and the AIC was determined for the transformation. If the AIC of the model containing the transformed variable was lower than for the model To show the improvement in the area under the ROC curve for our final model in comparison to the EuroScore model we applied the one-tailed Hanley-McNeil test [11] . The areas under the ROC curve for the presented models will be overoptimistic in comparison to the EuroScore model as it was developed in a different data set. To correct for overoptimism we generated 40 bootstrap samples using the software packages Microsoft Excel and Access. In a simulation study was shown that 40 bootstrap samples are as good as 200 (Harrell FE Jr., http://biostat.mc.vanderbilt.edu/twiki/ pub/Main/RmS/logistic.val.pdf). The areas under the ROC curves for the final models were corrected by the optimism in the apparent performance, the difference between the mean area of 40 bootstrap samples and the mean area of 40 tests in the original data.
Results
After aortic valve replacement with or without combined CABG the mortality rates were observed as 3.8% (N = 84) and 5.9% (N = 130) at 30 days and 3 months, respectively. Preoperative clinical characteristics which were identified as independent risk factors of 30-day and 3-month mortality are shown in Table 3 . The discriminative power of the models measured by the area under ROC curve (c-index) was 0.75 for both models. Including the selected laboratory values into the models increased the c-index up to 0.79 and 0.78, for 30-day and 3-month mortality, respectively. Several clinical characteristics were not further predictive and were not included in the models containing the laboratory variables as history of myocardial infarction, cardiac arrhythmias, diabetes mellitus and infection for 30-day mortality and history of myocardial infarction, infection and emergency procedure for 3-month mortality (Tables 3 and 4) .
The linear assumption of the logistic model was verified for all continuous variables. For several variables presented in Fig. 1a-d we suggested that transforming the continuous variable to a categorical ones may also be valid. Including the categorical variables for fasting glucose, creatininekinase and body mass index into the model for 30-day mortality instead of the continuous variables resulted in a slight decrease of the Akaike information criterion from 639 to 632. Including the categorical variables into the model for 3-month mortality, the Akaike information criterion remained relatively constant (from 847 to 845). For better medical interpretation and comparison between 30-day and 3-month mortality, we included the considered variable as categorical. All other continuous variables showed a clearly linear relation.
We compared our models to models using the variables of the logistic EuroScore as suggested for prediction of the operative risk after cardiac surgery [1] . In Fig. 2 a lower cindex for the logistic EuroScore model in our study population is shown in comparison to our regression models. The areas under the ROC curves for the final models containing the laboratory variables were corrected by the optimism in the apparent performance, which was 0.02 and 0.017 for the 30-day mortality model and the 3-month mortality model, respectively. The corrected c-indices for both models (0.769 and 0.766 for 30-day mortality and 3-month mortality, respectively) were significantly larger than for the EuroScore models ( p = 0.03 and p = 0.01 for 30-day mortality and 3-month mortality, respectively).
Discussion
In the present study, the predictive models for 30-day and 3-month mortality after AVR are based mainly on preoperative laboratory data.
We were able to identify preoperatively measured laboratory data as risk factors for operative mortality. Instead of renal insufficiency, preoperative myocardial ischaemia, chronic heart failure, our models included increasing creatinine concentration, the concentration of creatinine kinase, lower serum sodium concentrations. These laboratory values can be assigned to the well-known clinical risk factors used in other risk scores.
For other laboratory variables as total protein, antithrombine III (AT III) or partial thromboplastine time (PTT) the causes for the deviation from normality are miscellaneous: e.g. lower serum total protein and lower AT III levels may indicate increased risk in patients with dilution due to intravascular fluid overload [12] . But lower serum total protein can also be a marker for malnutrition, thereby increasing risk for infection [13] and mortality [14] . Nutritional support or albumin administration may be an appropriate therapy in these patients [15] . Low AT III levels lead to failure of activated clotting time to reach high levels during cardiopulmonary bypass even with adequate heparin doses with the subsequent risks. Our finding that AT III is included in the model for 3-month mortality independent from PTT and sodium indicates that lower AT III levels is an indicator for thromboembolic complications. Although no guidelines or clinical studies formally establish AT III monitoring and substitution [16] , our results may support such policy.
Fasting glucose was found to be a risk factor for both the model for 30-day and 3-month mortality. As we have described recently in a series of patients receiving coronary artery bypass surgery the preoperative measurement of fasting plasma glucose (FPG) can identify patients with diabetes, according to the new definitions of the American Diabetes Association (FPG ! 126 mg/dl [7.0 mmol/l] = diabetes mellitus [17] ), who have an increased morbidity and mortality rate during the perioperative and postoperative course [18] . Strict control of hyperglycaemia particularly in these patients is recommended.
We did not identify a low preoperative haematocrit as risk factor in contrast to the Cleveland Clinic Score. It can be a risk factor for mortality since the preoperative haematocrit correlates with the intraoperative haematocrit, which was found to be an important predictor of adverse outcome (up to 6 years) [19] . However, the correlation between preoperative to intraoperative haematocrit and subsequently the operative risk depends greatly on the perioperative management and the policy of blood products transfusion. Secondly, the haematocrit correlates with important risk factors such as female gender, low body weight and low surface area [19, 20] . Thus, other important risk stratification systems such as EuroScore or Parsonnet Score [1, 21] , did not find that a low preoperative haematocrit but female gender is a risk factor for mortality. Analogous in the Cleveland Clinic Score female gender and low body weight were not included in the Cleveland model although they were risk factors in their univariate analysis.
To summarize, the inclusion of laboratory risk factors into predictive model yield several advantages:
1. These new laboratory risk factors are accurately defined, showing no inter-observer variability. The more complex the variable definitions (e.g. EuroScore: 'preoperative critical state') the greater is the inter-observer variability. Variable clinical definitions depend largely on hospital specific diagnostic standards (e.g. EuroScore: diagnosis of pulmonary hypertension by SWAN-Ganz Catheter; diagnosis of carotid stenosis by Dopplersonography, etc.) and became inaccurate, when the screening for these diseases remains incomplete [22] . This issue may contribute to the observed variations in its accuracy at predicting risk in different surgical subgroups in two recent studies [23, 24] . Thus, it seems reasonable to include only objective parameters in risk scores, where variable definitions are accurate and consistent between the units. 2. The inclusion of laboratory data improved the AIC and the discriminative power of the models. For aortic valve replacement the optimism-corrected area under the ROC curve was significantly larger for the models containing laboratory values than for the EuroScore model. With our comparably small data set (N = 2189) we were able to achieve a similar validated c-index of 0.77 for prediction of 30-day mortality after aortic valve replacement in comparison to recently published models containing much more risk factors relying on larger databases as from the Northern New England Study Group (N = 5793, cindex = 0.75) [5] and for valve replacement from the Society of Cardiothoracic Surgeons of Great Britain and Ireland (N = 32839, c-index = 0.77) [6] and from the Society of Thoracic Surgeons (N = 409904, c-index = 0.735) [7] . 3. The identification of risk factors, as AT III, total proteins and fasting blood glucose, yields the opportunity to modify these parameters during the perioperative course with the intention to decrease the operative risk.
